![Nataskia Lampe](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Nataskia Lampe worked as an Associate Director of Regulatory Affairs at Lung Biotechnology PBC.
She then worked at AbbVie, Inc. as an Asset Strategy Leader for Neuroscience & Fibrosis from 2018 to 2021.
In 2021, she became the Vice President & Head of Regulatory Affairs at Pieris Pharmaceuticals, Inc. Ms. Lampe received her undergraduate degree from Tulane University School of Medicine and her graduate degree from Thomas Jefferson University.
Tidigare kända positioner av Nataskia Lampe
| Företag | Position | Slut |
|---|---|---|
| PIERIS PHARMACEUTICALS | Generell Rådgivare | 2022-08-01 |
| ABBVIE INC. | Företagsledare/Principal | 2021-08-01 |
Lung Biotechnology PBC
 Lung Biotechnology PBC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Generell Rådgivare | - |
Nataskia Lampes utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
31
Första gradens relationer
5
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
Thomas Jefferson University
 Thomas Jefferson University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AbbVie, Inc.
 AbbVie, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies | Health Technology |
Lung Biotechnology PBC
Lung Biotechnology PBC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Tulane University School of Medicine
 Tulane University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pieris Pharmaceuticals, Inc.
 Pieris Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and markets an anticalin-brand protein technology | Health Technology |
